午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Two ticket-system supplementary documents are being worked out!Some terms are basically confirmed
 
Author:中國銘鉉 企劃部  Release Time:2017-8-28 10:06:42  Number Browse:735
 
The medical network on August 28, a national two-ticket "fine print" is in the process of making a drum.

The blue that parker - currently in two votes is stepping up efforts to formulate rules, file the overall framework (chapter 7 of article 41) has been basically confirmed, including the support library, three scenarios can open three votes, and the shortage of cheap drugs, medicines and drugs and drugs prescribed by the state special national reserves can be temporarily does not perform the content such as "two votes" were written.

▍ respect the market rule

On January 11, 2017, the state department, health department, national development planning commission, national food drug safety administration, the national development and reform commission, ministry of industry and commerce, the state administration of taxation and the state administration of traditional Chinese medicine and so on eight departments jointly issued by the "on drug procurement in the public medical institutions in implementing the implementation of the" two votes "opinion (try out)", the symbol of two votes across the country officially fall to the ground.Subsequently, local documents were issued successively.

"After half a year later, the detailed rules for the more perfect and encountered in the process of adjustment in the execution of some of the actual operational level problems - how can conform to the policy guidance, and respect the market rule, but also can reflect the reasonable demands of the enterprise, we think they are short of one cannot."The source close to the document said to cypress blue.

The source said, at present, in the execution of two votes, implement the responsibility main body and main responsibilities defined there are still difficulties, including objective problems such as the complexity of the actual operation and so on all has given rise to the emergence of the detailed rules.

▍ article 41 in chapter 7, the content has changed

Cypress blue understands that the overall rules of the rules are 7 chapters of 41, including: general, organizational implementation, two-ticket definition, bill management, safeguard supervision, penalty and supplementary provisions.

It is worth noting that the "note management" specifically emphasizes identification and billing specifications.

On the comparison on January 11, issued by the public medical institutions and drug procurement in the implementation of the implementation of the "two votes" opinion (try out) ", in the fourth part of the content of the paper, in the paper on the management and staff identity details such as a large amount of refinement, at the same time increase the policy operability and normative.

At the same time, the definition of "two voting system" requires "change" :

Shareholding relationship definition: it is more than 50% of the shareholding subsidiary company set up by the group company.

Change of controlling relation: after obtaining the business change instrument, it should be made public in time.

If the change of enterprise ownership structure changes to more than 50% of the holding relationship, it shall be filed with the provincial health department within three working days after the completion of the business procedures, and shall be shown on the centralized procurement platform.

In order to guarantee the needs of medical institutions, the detailed rules suggest that four types of drugs are approved by the local health and family planning commission, which may not implement the "two-ticket system", including:

1. Include medicines for low-priced medicines purchased in the provinces.

2. To include in the country's twenty major diseases protection, special treatment for diseases, and to the local health and family planning commission to approve the required shortage of drugs;

3. Major natural disasters, major outbreaks, major emergencies and patient emergencies, emergency procurement of medicines or national stockpile drugs;

4. Special medicines stipulated by the state (regardless of one or two).

In addition, put forward the policy to support a library, a drug regulators around the different (province) for the enterprise to set up library, the third party logistics, and so on can meet the demand of the direction of the reform to provide policy support, in order to make sure drug supplies, promote the formation of a unified national market.

▍ two votes VS three votes

At the same time, the detailed rules also make further demands on the allocation of issues. Three conditions are not considered as one vote, but only one invoice is allowed, including:

1. Drug transfer between the pharmaceutical production or circulation group enterprises and their wholly owned or controlled subsidiaries (more than 50% of the shares);

2. The drug allocation between its wholly-owned or controlling subsidiaries (more than 50% of the shares);

3. The drug transfer between the same overseas third party direct holding (more than 50% of shares) and domestic subsidiaries.

As a result of the actual situation, the "detailed rules" also made clear that three cases were allowed to open three tickets, which were approved by the local health and family planning commission.

1. The distribution of medicines of special remote and inaccessible township or village medical institutions shall be determined and publicized by various provinces and cities;

2. Extension (or commissioning of dispensing points) of local communities or rural health sites;

3. Import to domestic or domestic branded product distribution rights (including management and rights, distribution rights) transfer all of the national general agent can be regarded as production enterprises, build system of the national general agent for the record, registration conditions must meet at the same time:

Overall transfer of distribution rights;In the same period, over 3 years and specific compliance;There is only one general agent in the whole country.

▍ two votes regulation: led by the department of public health

Detailed rules for the proposed health departments at all levels is led by the regulation of "two votes" department, health department at all levels should be responsible for joint related departments to carry out the "two votes" supervision, actively promoting the implementation of the "two votes", and will be included in the implementation of the "two votes" hospital evaluation system;The provisions of 30 days of payment shall be implemented.

Since the health department has become the main branch of the two-ticket regulation, the penalty section is also divided into two parts: the punishment for enterprises and medical institutions:

Refers to the punishments for enterprises, for not according to the provisions of the "two votes" requirements of the pharmaceutical producing enterprises and pharmaceutical circulation enterprises into the blacklist, directly cancel the bid, the supply of public medical institution qualification.

The punishment for medical institutions is that the health departments at all levels should report the criticism to the medical institutions that are not in place to implement the two-ticket system and the lax inspection certificate, and hold the responsible person responsible.

It remains to be seen how much the new rules will improve the current two-ticket implementation and circulation market.
 
Previous article:One ticket system, 65 consumables, reagent manufacturers direct distribution
Next article:The ministry of industry and information technology (mii) has subsidized 550 million Chinese traditional Chinese medicine varieties with the most opportunity (list)
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號